Form 4: Freshpet Executive Thembeka Machaba Acquires 70,810 Shares Through Option Vesting
SEC Form 4 Filing
Thembeka Machaba, Chief Human Resources Officer at Freshpet, Inc., acquired 70,810 shares of common stock through the vesting of performance-based options.
Summary
- Thembeka Machaba, the Chief Human Resources Officer of Freshpet, Inc., acquired 70,810 shares of Freshpet's common stock.
- This acquisition occurred on February 10, 2025, due to the vesting of performance-based options.
- The options were granted on December 24, 2020, under the company's 2014 Omnibus Incentive Plan.
- The vesting was contingent upon achieving certain performance goals over a four-year period ending December 31, 2024, and Ms. Machaba's continued employment.
- The performance criteria were partially met, leading to the vesting of 70,810 out of the initially granted 82,031 options.
- The exercise price of these options is $142.79.
- Following this transaction, Ms. Machaba directly owns 70,810 derivative securities (options).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It reflects a standard executive compensation event. The partial vesting suggests some success but also some shortcomings in meeting performance goals.
Positives
- The vesting of performance-based options suggests that some performance goals were met, which could be viewed positively.
- The executive's continued employment and vesting of options align her interests with the company's success.
Negatives
- The performance criteria were only partially met, resulting in only 70,810 of the 82,031 options vesting.
Industry Context
This filing is a routine disclosure related to executive compensation and is common for publicly traded companies. It provides transparency into the equity holdings and incentives of key personnel.
Stakeholder Impact
- Shareholders may view the vesting of options as an indicator of management's alignment with company performance.
- Employees may see this as a reflection of the company's compensation practices.
Key Dates
| Date | Description |
|---|---|
| 2020-12-24 | Reporting person was granted 82,031 performance-based options pursuant to the Issuer's 2014 Omnibus Incentive Plan. |
| 2024-12-31 | Conclusion of a four-year performance period for the performance-based options. |
| 2025-02-10 | Transaction date: Vesting of 70,810 options. |
| 2030-12-24 | Expiration date of the options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.